期刊文献+

重型乙型肝炎血清HBV DNA水平与肝功能及免疫指标的关系研究 被引量:12

A study on the correlation between the level of serum HBV DNA and liver function and immunological index in patients with severe hepatitis B
原文传递
导出
摘要 目的 探讨重型乙型肝炎患者血清HBV DNA水平与肝损害程度以及血清免疫指标之间的关系.方法 应用荧光定量聚合酶链反应法和酶联免疫吸附法(ELISA)分别检测197例乙肝患者血清HBVDNA水平与乙型肝炎病毒血清标志物(HBVM).结果 重型乙型肝炎患者血清HBV DNA水平显著低于慢乙肝重度,慢乙肝轻、中度及急性乙肝(P<0.01);重型乙型肝炎患者HBeAg阴性率最高(P<0.05);重型乙肝患者血清HBV DNA水平与ALT、TBil无相关性,与C3、C4呈显著正相关(P<0.01),与PT、IgG、IgA、IgM呈显著负相关(P<0.05~0.01);重型乙型肝炎死亡患者血清HBV DNA水平显著低于存活者(P<0.05).结论 重型乙型肝炎血清HBV DNA复制水平低,HBeAg阴性率高,与病毒变异有关;重型乙型肝炎血清HBV DNA水平与肝功能及免疫指标有良好相关性;定量检测重型乙型肝炎患者血清HBV DNA对判断病情危重程度、指导抗病毒治疗和估计预后有重要意义. Objective To explore the correlation between the level of serum HBV DNA and the degree of liver damage and immunological index in patients with severe hepatitis B. Methods The levels of serum HBV DNA and HBV markers were measured by fluorescence quantitanve PCR and ELISA respectively in 197 cases with hepatitis B. Results The levels of serum HBV DNA in patients with severe hepatitis B were lower significandy than those in patients with mild, moderate, heavy chronic hepatitis B and acute hepatitis B( P 〈 0.01 );The negative rate of HBeAg in patients with severe hepatitis ]3 was the highest( P 〈 0.05);The level of serum HBV DNA in patients with severe hepatitis B had not correlation with ALT and TB, but had significantly positive correlation with C3 and C4 (P 〈 0.01 ), and significantly negative correlauon with PT, IgG, IgA and IgM (P 〈 0.05- 0.01 );The levels of serum HBV DNA in dead patients with severe hepatitis B were lower significantly than those in survivals(P 〈 0, 05).Conchlsions Low levels of HBV duplication and high negative rate of HBeAg can result from viral mutant; there is a good correlation between the levels of serum HBV DNA and liver function and immunological index in patients with severe hepatitis B;Quantitative measurement of serum HBV DNA is significant for estimating the degree of illness,instructing antivirus therapy, and evaluating prognosis.
出处 《中国基层医药》 CAS 2006年第9期1449-1450,共2页 Chinese Journal of Primary Medicine and Pharmacy
基金 广东省汕头市科技计划项目[汕市财文(2002)70号]
关键词 肝炎 乙型 DNA 病毒 酶联免疫吸附测定 聚合酶链反应 预后 Hepatitis B DNA,viral Enzyme-linked immunosorben assay Polymerase chain reaction Prognosis
  • 相关文献

参考文献6

二级参考文献16

  • 1黄呈辉.HBV DNA定量检测及临床应用的研究进展[J].国外医学(流行病学.传染病学分册),1996,23(4):154-157. 被引量:22
  • 2张复春,吴婉芬,董惠卿,蔡晓莉,魏绍静,冼超.定量聚合酶链反应检测血清中HBV DNA及其临床应用[J].中华传染病杂志,1997,15(1):24-27. 被引量:130
  • 3黄德庄 张建成 等.定量聚合酶链反应检测乙型和丁型肝炎患者HBV DNA[J].当代医师杂志,1996,12(1):7-7.
  • 4Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001, 34:1225-1241
  • 5Bock CT, Tillmann H, Torresi J, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology. 2002, 122:264-273.
  • 6Stuyver LJ, Locarnini SA, Lok A, et al. Nomenclature for antiviralresistant human hepatitis B virus mutations in the polymerase region.Hepatology 2001, 33 : 751-757.
  • 7Torresi J, Earnest-Silveira L, Deliyarmis G, et al. Reduced antigeriicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology, 2002, 293:305-313.
  • 8Angus P, Vaughan R, Xiong S, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology. 2003, 125:292-297.
  • 9Bozdayi AM, Uzunalimoglu O, Turkyilmaz AR, et al. YSDD: a novel mutation in HBV DNA polyrnerase confers clinical resistance to lamivudine. J Viral Hepatitis. 2003, 10:256-265.
  • 10Lindh M, Furuta Y, Vahlne A, et al. Emergence of precore TAG mutation during hepatitis B e serocoversion and its dependence on pregenomic base pairing between uncleotides 1858 and 1896. J Infect Dis, 1995,172(5): 1343

共引文献14074

同被引文献83

引证文献12

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部